Gastrointestinal Disease, Nutrition / 24.06.2024

Crohn's disease is a type of inflammatory bowel disease. It causes inflammation in the digestive tract, which can lead to severe symptoms. The inflammation often spreads deep into the layers of affected bowel tissue. Crohn's disease can be painful and sometimes may lead to life-threatening complications. abdominal-pain-crohns_pexels-sora-shimazaki-5938358 Symptoms of Crohn's Disease Symptoms of Crohn's disease vary from mild to severe. Common symptoms include diarrhea, fever, fatigue, abdominal pain and cramping. People with Crohn's disease might also experience blood in their stool, mouth sores, reduced appetite and weight loss. The disease can affect different parts of the digestive tract in different people. The symptoms can change over time, with periods of severe symptoms (flares) and periods of no or mild symptoms (remission). Causes and Risk Factors The exact cause of Crohn's disease remains unknown. However, several factors may contribute to its development. These include immune system malfunctions, genetics and environmental factors. Crohn's disease tends to run in families, suggesting a genetic link. Smoking increases the risk of developing the disease and can make symptoms worse. People living in urban areas or industrialized countries have a higher risk, possibly due to diet and lifestyle factors. (more…)
Author Interviews, Gastrointestinal Disease, Immunotherapy / 17.05.2023

MedicalResearch.com Interview with: Marla Dubinsky, M.D. Professor of Pediatrics and Medicine Co-director of the Susan and Leonard Feinstein IBD Clinical Center Chief of the Division of Pediatric Gastroenterology and Nutrition Icahn School of Medicine at Mount Sinai     MedicalResearch.com: What is the background for this study? How does MIRIKIZUMAB differ from other medications for UC? Response: This is a phase 2 study to assess the PK (pharamcokinetics), safety and efficacy of mirikizumab in pediatric ulcerative colitis (UC). Mirikizumab is a humanized monoclonal antibody that specifically binds to the p19 subunit of interleukin-23, a key inflammatory mediator in inflammatory bowel disease. (more…)
Author Interviews, Gastrointestinal Disease, Mental Health Research / 08.02.2023

MedicalResearch.com Interview with: Yuan, Zhongshang PhD Department of Biostatistics School of Public Health Shandong University Jinan, Shandong, China What is the background for this study? Response: Comorbidities and genetic correlations between gastrointestinal tract diseases and psychiatric disorders have been widely reported, with the gut-brain axis (GBA) hypothesized as a potential biological basis. However, it is unclear the degree to which the shared genetic determinants contribute to these associations underlying GBA. (more…)